J&J Unit Faces 1st Morcellator Suit Since FDA Warning
By Sindhu Sundar ( May 6, 2014, 7:39 PM EDT) -- A Johnson & Johnson unit on Thursday was hit with the first suit over its morcellator product used in a now controversial uterine fibroid removal procedure that the U.S. Food and Drug Administration has warned could spread cancerous tissue outside of the uterus....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.